SCHEMBL8875222

SCHEMBL8875222

CC1(C)CC(C)(C)c2cc(C#Cc3ccc(CC(=O)O)o3)ccc2S1

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ RARA P10276 6/20 0.39
▸ RARB P10826 6/20 0.39
▸ RARG P13631 6/20 0.39
▸ CYP3A4 P08684 3/20 0.37
▸ CYP26A1 O43174 2/20 0.37
▸ CRABP2 P29373 1/20 0.37
▸ HSPA9 P38646 1/20 0.35
▸ KMT2A Q03164 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8865081 0.87 RARA (0.40) RARARARBRARGCYP3A4CYP26A1
SCHEMBL8876884 0.84 RARA (0.33) RARARARBRARGHSPA9
SCHEMBL8875860 0.84 RARA (0.33) RARARARBRARGHSPA9
SCHEMBL6669237 0.83 RARB (0.53) RARARARBRARGCYP3A4CYP26A1
SCHEMBL9264097 0.82 CYP26A1 (0.56) RARARARBRARGCYP3A4CYP26A1
SCHEMBL8874983 0.80 RARB (0.39) RARARARBRARGCYP3A4CYP26A1
SCHEMBL8875276 0.79 CYP3A4 (0.45) RARARARBRARGCYP3A4CYP26A1
SCHEMBL8875643 0.78 ALDH1A1 (0.32) RARARARBRARGKMT2AKDM4E
SCHEMBL8865070 0.77 RARA (0.38) RARARARBRARGCYP3A4CYP26A1
SCHEMBL8876089 0.76 CYP3A4 (0.46) RARARARBRARGCYP3A4CYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616597-A ANTIACNE, ANTIPSORIASIS COMPOUNDS ALLERGAN (US) 1997-04-01 — — US disclosed
US-5599819-A SKIN DISORDERS ALLERGAN 1997-02-04 — — US disclosed
US-5534516-A Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1, 2, 3, 4-tetrahydroquinolinyl group having retinoid-like activity ALLERGAN 1996-07-09 — — US disclosed
EP-0419130-B1 Acetylenes disubstituted with a heteroaromatic group and A 2-substituted chromanyl, thiochromanyl or 1,2,3,4- tetrahydroquinolinyl group having retinoid-like activity ALLERGAN INC (US) 1995-11-15 — — EP disclosed
US-5407937-A Skin disorders, skin cancer ALLERGAN, INC. (US) 1995-04-18 — — US disclosed
US-5272156-A Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity ALLERGAN, INC. (US) 1993-12-21 — — US disclosed
EP-0555235-A4 ACETYLENES DISUBSTITUTED WITH A HETEROAROMATIC GROUP AND A 2-SUBSTITUTED CHROMANYL, THIOCHROMANYL OR 1,2,3,4-TETRAHYDROQUINOLINYL GROUP HAVING RETINOID-LIKE ACTIVITY — 1993-11-10 — — EP disclosed
EP-0555235-A1 ACETYLENES DISUBSTITUTED WITH A HETEROAROMATIC GROUP AND A 2-SUBSTITUTED CHROMANYL, THIOCHROMANYL OR 1,2,3,4-TETRAHYDROQUINOLINYL GROUP HAVING RETINOID-LIKE ACTIVITY ALLERGAN, INC. (US) 1993-08-18 — — EP disclosed
US-5183827-A Skin disorders ALLERGAN, INC. (US) 1993-02-02 — — US disclosed
WO-1992006092-A1 ACETYLENES DISUBSTITUTED WITH A HETEROAROMATIC GROUP AND A 2-SUBSTITUTED CHROMANYL, THIOCHROMANYL OR 1,2,3,4-TETRAHYDROQUINOLINYL GROUP HAVING RETINOID-LIKE ACTIVITY ALLERGAN, INC. (US) 1992-04-16 — — WO disclosed
US-5045551-A Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity ALLERGAN, INC. (US) 1991-09-03 — — US disclosed
EP-0419130-A2 Acetylenes disubstituted with a heteroaromatic group and A 2-substituted chromanyl, thiochromanyl or 1,2,3,4- tetrahydroquinolinyl group having retinoid-like activity ALLERGAN, INC. (US) 1991-03-27 — — EP disclosed
Send feedback